Figures & data
Table 1. Comparison between the groups according to the level of blood sugar, glomerular area (% of control), immunoexpression fibronectin percentage, immunoexpression i-NOS percentage, proteinuria (mg/dL), blood glucose (mg/dL).
Figure 2. H & E staining (×100 magnification): (a) control group (non-diabetes group), (b) diabetes group, (c) diabetes and enalapril, (d) diabetes and trimetazidine.
![Figure 2. H & E staining (×100 magnification): (a) control group (non-diabetes group), (b) diabetes group, (c) diabetes and enalapril, (d) diabetes and trimetazidine.](/cms/asset/73c2e04d-0471-48ac-85d5-0554ec07ca4b/irnf_a_930331_f0002_b.jpg)
Figure 3. Fibronectin immunostaining (×100 magnification); (a) control group (non-diabetes group), (b) diabetes group, (c) diabetes and enalapril, (d) diabetes and trimetazidine.
![Figure 3. Fibronectin immunostaining (×100 magnification); (a) control group (non-diabetes group), (b) diabetes group, (c) diabetes and enalapril, (d) diabetes and trimetazidine.](/cms/asset/998ef13e-090b-4c71-8911-f16765512f07/irnf_a_930331_f0003_b.jpg)
Figure 4. NOS-2 (i-NOS) immunostaining (×100 magnification): (a) control group (non-diabetes group), (b) diabetes group, (c) diabetes and enalapril, (d) diabetes and trimetazidine.
![Figure 4. NOS-2 (i-NOS) immunostaining (×100 magnification): (a) control group (non-diabetes group), (b) diabetes group, (c) diabetes and enalapril, (d) diabetes and trimetazidine.](/cms/asset/7d4c5e3b-bf02-465f-b11a-f2183bf8bfbe/irnf_a_930331_f0004_b.jpg)
Figure 5. H & E staining (×40 magnification); (a) control group (non-diabetes group), (b) diabetes group, (c) diabetes and enalapril, (d) diabetes and trimetazidine.
![Figure 5. H & E staining (×40 magnification); (a) control group (non-diabetes group), (b) diabetes group, (c) diabetes and enalapril, (d) diabetes and trimetazidine.](/cms/asset/c3bf30a5-330b-4b46-97c0-0ed5d5609b98/irnf_a_930331_f0005_b.jpg)
Table 2. Comparison between the groups according to the mean glomerulosclerosis, immunoexpression fibronectin, immunoexpression i-NOS score.